1. Home
  2. OVID vs IAF Comparison

OVID vs IAF Comparison

Compare OVID & IAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • IAF
  • Stock Information
  • Founded
  • OVID 2014
  • IAF 1985
  • Country
  • OVID United States
  • IAF United States
  • Employees
  • OVID N/A
  • IAF N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • IAF Finance/Investors Services
  • Sector
  • OVID Health Care
  • IAF Finance
  • Exchange
  • OVID Nasdaq
  • IAF Nasdaq
  • Market Cap
  • OVID 117.3M
  • IAF 123.6M
  • IPO Year
  • OVID 2017
  • IAF N/A
  • Fundamental
  • Price
  • OVID $1.32
  • IAF $13.39
  • Analyst Decision
  • OVID Strong Buy
  • IAF
  • Analyst Count
  • OVID 4
  • IAF 0
  • Target Price
  • OVID $3.13
  • IAF N/A
  • AVG Volume (30 Days)
  • OVID 1.7M
  • IAF 90.4K
  • Earning Date
  • OVID 11-13-2025
  • IAF 01-01-0001
  • Dividend Yield
  • OVID N/A
  • IAF 11.44%
  • EPS Growth
  • OVID N/A
  • IAF N/A
  • EPS
  • OVID N/A
  • IAF N/A
  • Revenue
  • OVID $6,651,000.00
  • IAF N/A
  • Revenue This Year
  • OVID $1,081.80
  • IAF N/A
  • Revenue Next Year
  • OVID N/A
  • IAF N/A
  • P/E Ratio
  • OVID N/A
  • IAF N/A
  • Revenue Growth
  • OVID 1070.95
  • IAF N/A
  • 52 Week Low
  • OVID $0.24
  • IAF $3.60
  • 52 Week High
  • OVID $2.01
  • IAF $4.59
  • Technical
  • Relative Strength Index (RSI)
  • OVID 41.52
  • IAF 89.57
  • Support Level
  • OVID $1.27
  • IAF $13.31
  • Resistance Level
  • OVID $1.44
  • IAF $13.65
  • Average True Range (ATR)
  • OVID 0.10
  • IAF 0.82
  • MACD
  • OVID -0.04
  • IAF 0.16
  • Stochastic Oscillator
  • OVID 14.29
  • IAF 91.16

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About IAF abrdn Australia Equity Fund Inc.

Aberdeen Australia Equity Fund Inc is a non-diversified closed-end investment management company. With a core focus on long-term capital appreciation, it invests predominantly in equity securities listed on the Australian Stock Exchange. Its secondary objective is current income, which it expects to derive from dividends and interest on Australian corporate and governmental securities. Its investment portfolio comprises diversified sectors that include Financials, Health Care, Materials, Information Technology, Real Estate, and other sectors.

Share on Social Networks: